NCT00549913 - Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions

Degenerative Disc DiseaseSpondylolisthesisSpinal Stenosis

Interventions

BIOLOGICAL

NeoFuse

immunoselected, culture-expanded, nucleated, allogeneic MPCs (NeoFuse) combined with MasterGraft Resorbable Ceramic Granules in subjects requiring posterior lumbar interbody fusion with NuVasive's radiolucent PEEK OPTIMA cage

PROCEDURE

posterolateral spinal fusion with instrumentation

autograft in subjects requiring posterior lumbar interbody fusion with NuVasive's radiolucent PEEK OPTIMA cage

Trial Locations (1)

10021

Hospital for Special Surgery, New York